Alnylam Pharmaceuticals Inc. (ALNY)

Alnylam Pharmaceuticals Inc. (ALNY $461.14)
- $461.14 Cap: $61.06B
- View ALNY Profile
- View Questions on ALNY

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Alnylam Pharmaceuticals Inc. (ALNY $461.14)
- $461.14 Cap: $61.06B
- View ALNY Profile
- View Questions on ALNY

Q: I have owned ALNY for a couple of years now and it has done very well. As there are no other questions I assume you likely don't follow it. It recently spiked up again and I'm starting to get worried that I should sell some. I realize you can't give personal advice. However, can you provide me analytics that would help me to make a more informed decision. Thanks.

Read Answer Asked by Murray on September 15, 2025